Pharma Journalist -

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its investigational drug pevonedistat for…
Read More...

Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. The vaccine candidate,…
Read More...

Sangamo Therapeutics, Inc. announced that it has executed a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies to address…
Read More...

Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies. The data, published…
Read More...

Harbour BioMed (HBM) and Viva Biotech (Shanghai) Ltd. announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and…
Read More...

UCB announced an agreement to enter into a world-wide, exclusive license agreement with Roche and Genentech, a member of the Roche Group, for the global development and…
Read More...

Piramal Pharma Solutions announced that it is providing Bolt Biotherapeutics (Bolt) with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing…
Read More...

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, and Celonic Group, a premium biopharmaceutical contract development and…
Read More...

At the direction of President Donald J. Trump, U.S. International Development Finance Corporation (DFC) Chief Executive Officer Adam Boehler will today sign a letter of interest (LOI)…
Read More...

Karuna Therapeutics, Inc. an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with…
Read More...